Saturday, May 28, 2022 4:19:46 AM
I have to be honest, For this incredible science, its been not too hard a wait for me. I have patience for years. Some of my best plays are set it and forget it. Leave 50k floating on companies to wake up one day and your account have an extra 200k in it. Sometimes more!!
With RGBP, I fully expect more! Dr Koos will be working on funding and advertising of IP. And with the science finally catching up with NR2F6, and gene suppression, it truly is just a sit, wait, and watch Dr Koos position this companies IP for marketability. Not only that but to be the unquestionable front running list of agonist and antagonist for Nuclear receptor subfamily 2 group F member 6: now proven to be extremely significant.(hint)
Koos is working so hard, because the science is moving forward, and he finally has IP that is needed! When you can save any other Pharma time while providing clear direction, that becomes valuable. In some cases extremely valuable. The IP that Regen has obtained in some cases took a decade of research and study to achieve. You can bet you arse, some Pharma will find value in the short cut RGBP IP will
Provide. Especially in cutting edge MRNA!!
Cheers to the Longs! This will be exploding from current levels. Ive got some DD im seeing is over looked. Stay thirsty my friends, and stay tuned!
This company ran from .002 to .08, and is now in provably better position then ever to capitalize on its NR2F6 science. Watch what happens next. Warning issued.
Sometimes its Skil, Sometimes its Luc.
I Appreciate All Member Follows!
Desperate Sellers Become Desperate Buyers. Vice Versa
ALL IMHO.
North Bay Resources Announces Assays up to 5 oz/ton Gold, 1.5 oz/ton Platinum, 0.5 oz/ton Palladium, and 0.5 oz/ton Rhodium at Mt. Vernon Gold Mine, Sierra County, California • NBRI • Oct 4, 2024 9:15 AM
Basanite, Inc. Appoints Ali Manav as Interim Chief Executive Officer • BASA • Oct 3, 2024 9:15 AM
Integrated Ventures Announces Launch of MedWell Facilities, LLC and Lease Agreement with Giant Fitness Clubs • INTV • Oct 3, 2024 8:45 AM
Beyond the Horizon: Innovative Drug Combinations Offer New Hope for Alzheimer's and More • NVS • Oct 3, 2024 8:45 AM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service To Enhance Natural Rubber Industry's Ability to Report on Sustainable and Ethical Supply Chains • SMX • Oct 3, 2024 7:00 AM
Transforming Alzheimer's Treatment: Innovative Combinations to Boost Cognition • PFE • Oct 2, 2024 9:00 AM